Role of MiR-126a-3p in Endothelial Injury in Endotoxic Mice

Maoping Chu1, Shanshan Qin2, Rongzhou Wu1

  • 1Children's Heart Center, the Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, China, 325027.

Critical Care Medicine
|March 12, 2016
PubMed
Abstract

Insights

Sepsis causes vascular injury, and this study found that miR-126a-3p is down-regulated in endotoxic conditions. Restoring miR-126a-3p levels improved vascular function and survival in mice, suggesting it as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Vascular Biology
  • Sepsis Research

Background:

  • Sepsis is a major cause of mortality, with vascular injury being a key contributor.
  • Understanding the molecular mechanisms of sepsis-induced vascular dysfunction is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the expression profile of microRNAs in endotoxic vascular walls.
  • To determine the role of specific microRNAs, particularly miR-126a-3p, in sepsis-related vascular injury.

Main Methods:

  • Lipopolysaccharide (LPS) was used to induce endotoxemia in a mouse model.
  • MicroRNA expression profiling was performed on aortic tissues.
  • In vitro and in vivo experiments were conducted to assess the functional impact of miR-126a-3p manipulation.

Main Results:

  • Down-regulation of miR-126a-3p was observed in endotoxic mouse arteries and human septic vessels.
  • miR-126a-3p down-regulation led to increased endothelial cell apoptosis and decreased proliferation/migration.
  • Over-expression of miR-126a-3p attenuated endotoxemia-induced vascular injury and improved survival rates in mice.

Conclusions:

  • Vascular microRNAs, such as miR-126a-3p, play a significant role in endotoxemia-induced vascular injury.
  • miR-126a-3p represents a potential novel therapeutic target for sepsis-related vascular complications and mortality.

Related Concept Videos